Glenmark Pharma to sale of up to 96,09,571 equity s of Glenmark Life Sciences Limited (“GLS”) representing 7.84% of the issued and paid‐up equity capital by way of an offer for sale on 11th July (Non-Retail) and 12th July (Retail) at the floor price of Rs 810 per Equity (8% Discount from CMP). live #FinancialAdvice #Investment #FinancialNews live https://earnfree.in Glenmark Pharma to sale of up to 96,09,571 equity s of Glenmark Life Sciences Limited (“GLS”) representing 7.84% of the issued and paid‐up equity capital by way of an offer for sale on 11th July (Non-Retail) and 12th July (Retail) at the floor price of Rs 810 per Equity (8% Discount from CMP). live #FinancialAdvice #Investment #FinancialNews live https://earnfree.in

Glenmark Pharma to sale of up to 96,09,571 equity s of Glenmark Life Sciences Limited (“GLS”) representing 7.84% of the issued and paid‐up equity capital by way of an offer for sale on 11th July (Non-Retail) and 12th July (Retail) at the floor price of Rs 810 per Equity (8% Discount from CMP).
live #FinancialAdvice #Investment #FinancialNews live https://earnfree.in Glenmark Pharma to sale of up to 96,09,571 equity s of Glenmark Life Sciences Limited (“GLS”) representing 7.84% of the issued and paid‐up equity capital by way of an offer for sale on 11th July (Non-Retail) and 12th July (Retail) at the floor price of Rs 810 per Equity (8% Discount from CMP).
live #FinancialAdvice #Investment #FinancialNews live https://earnfree.in

Leave a Reply

Your email address will not be published. Required fields are marked *

Banking Giants Report Record Profits: HDFC Bank, Kotak Mahindra Bank, and YES Bank Q1Gold Bullish Signal Hold SupportTop Dividend Paying Stocks